BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33829548)

  • 1. Polypharmacy and saliva volumes in the northeast of Germany - The Study of Health in Pomerania.
    Laugisch O; Holtfreter B; Pink C; Samietz S; Völzke H; Kocher T
    Community Dent Oral Epidemiol; 2022 Apr; 50(2):139-146. PubMed ID: 33829548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interrelationship between xerogenic medication use, subjective oral dryness and tooth wear.
    Alwaheidi HAA; O'Toole S; Bernabé E
    J Dent; 2021 Jan; 104():103542. PubMed ID: 33276080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 diabetes mellitus, xerostomia, and salivary flow rates.
    Moore PA; Guggenheimer J; Etzel KR; Weyant RJ; Orchard T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):281-91. PubMed ID: 11552145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of xerostomia and hyposalivation in the nursing home and the relation with number of prescribed medication].
    van der Putten GJ; Brand HS; Bots CP; van Nieuw Amerongen A
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):30-6. PubMed ID: 12629908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the use of xerogenic medications for chronic medical and dental conditions among adult day health participants.
    Lam A; Kiyak A; Gossett AM; McCormick L
    Consult Pharm; 2009 Oct; 24(10):755-64. PubMed ID: 20017410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of medical status, medications, and salivary flow rates in adults of different ages.
    Navazesh M; Brightman VJ; Pogoda JM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Feb; 81(2):172-6. PubMed ID: 8665310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
    Nederfors T
    Swed Dent J Suppl; 1996; 116():1-70. PubMed ID: 8813731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xerogenic Medications as a Predictor for Dental Health Intervention in People with Dementia.
    Tan ECK; Lexomboon D; Häbel H; Fastbom J; Eriksdotter M; Johnell K; Sandborgh-Englund G
    J Alzheimers Dis; 2020; 75(4):1263-1271. PubMed ID: 32417782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium.
    Fortuna G; Whitmire S; Sullivan K; Alajbeg I; Andabak-Rogulj A; Pedersen AML; Vissink A; di Fede O; Aria M; Jager DJ; Noll J; Jensen SB; Wolff A; Brennan MT
    Clin Oral Investig; 2023 Jan; 27(1):235-248. PubMed ID: 36269468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication and dry mouth: findings from a cohort study of older people.
    Thomson WM; Chalmers JM; Spencer AJ; Slade GD
    J Public Health Dent; 2000; 60(1):12-20. PubMed ID: 10734611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xerostomia and medication: a cross-sectional study in long-term geriatric wards.
    Desoutter A; Soudain-Pineau M; Munsch F; Mauprivez C; Dufour T; Coeuriot JL
    J Nutr Health Aging; 2012; 16(6):575-9. PubMed ID: 22660000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of medication-induced xerostomia and effect of treatment.
    Ito K; Izumi N; Funayama S; Nohno K; Katsura K; Kaneko N; Inoue M
    PLoS One; 2023; 18(1):e0280224. PubMed ID: 36634078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of anti-hypertensives and type 2 diabetes on salivary flow and total antioxidant capacity.
    Djukić LJ; Roganović J; Brajović MD; Bokonjić D; Stojić D
    Oral Dis; 2015 Jul; 21(5):619-25. PubMed ID: 25689395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants.
    Janket SJ; Jones J; Rich S; Miller D; Wehler CJ; Van Dyke TE; Garcia R; Meurman JH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):223-30. PubMed ID: 17234540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xerostomia, xerogenic medications and food avoidances in selected geriatric groups.
    Loesche WJ; Bromberg J; Terpenning MS; Bretz WA; Dominguez BL; Grossman NS; Langmore SE
    J Am Geriatr Soc; 1995 Apr; 43(4):401-7. PubMed ID: 7706631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study.
    Mielke N; Huscher D; Douros A; Ebert N; Gaedeke J; van der Giet M; Kuhlmann MK; Martus P; Schaeffner E
    BMC Geriatr; 2020 Jan; 20(1):22. PubMed ID: 31964342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dental caries experience and use of prescription medications among people aged 60+ in South Australia.
    Thomson WM; Slade GD; Spencer AJ
    Gerodontology; 1995 Dec; 12(12):104-10. PubMed ID: 9084298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between polypharmacy, xerostomia, gustatory sensitivity, and swallowing complaints in the elderly: A multidisciplinary approach.
    Fernandes MS; Castelo PM; Chaves GN; Fernandes JPS; Fonseca FLA; Zanato LE; Gavião MBD
    J Texture Stud; 2021 Apr; 52(2):187-196. PubMed ID: 33191538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
    Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
    Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mucosal lesions in older people: relation to salivary secretion, systemic diseases and medications.
    Lynge Pedersen AM; Nauntofte B; Smidt D; Torpet LA
    Oral Dis; 2015 Sep; 21(6):721-9. PubMed ID: 25754744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.